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ABSTRACT
Although many tools have been developed to analyze small RNA sequencing (sRNA-Seq) data, it remains challenging to accurately analyze the small
RNA population, mainly due to multiple sequence
ID assignment caused by short read length. Additional issues in small RNA analysis include low consistency of microRNA (miRNA) measurement results
across different platforms, miRNA mapping associated with miRNA sequence variation (isomiR) and
RNA editing, and the origin of those unmapped reads
after screening against all endogenous reference sequence databases. To address these issues, we built
a comprehensive and customizable sRNA-Seq data
analysis pipeline––sRNAnalyzer, which enables: (i)
comprehensive miRNA profiling strategies to better handle isomiRs and summarization based on
each nucleotide position to detect potential SNPs
in miRNAs, (ii) different sequence mapping result
assignment approaches to simulate results from
microarray/qRT-PCR platforms and a local probabilistic model to assign mapping results to the mostlikely IDs, (iii) comprehensive ribosomal RNA filtering for accurate mapping of exogenous RNAs and
summarization based on taxonomy annotation. We
evaluated our pipeline on both artificial samples (including synthetic miRNA and Escherichia coli cultures) and biological samples (human tissue and
plasma). sRNAnalyzer is implemented in Perl and
available at: http://srnanalyzer.systemsbiology.net/.
INTRODUCTION
The function and application of small non-coding RNAs
(ncRNA), especially microRNA (miRNA) has gained significant interest in recent years (1). miRNAs are 17–23 ntlong evolutionarily conserved regulatory RNAs. Numerous
reports have shown the existence of RNA molecules, in* To

cluding miRNA, in various bodily fluids (2,3). These extracellular RNAs are either encapsulated in lipid vesicles
or complexed with proteins to prevent RNase degradation.
The spectrum of extracellular miRNA in various body fluids correlates with physiopathological conditions, and it has
been suggested that the concentration changes of specific
extracellular miRNAs can be used as biomarkers for disease
diagnosis (3–5). Therefore, the ability to accurately profile
and quantify the small RNA content in biological samples
is critical for further development of miRNA-based applications. Although many experimental and computational
tools have been developed (6–9), it is still a challenge to accurately and comprehensively analyze the small RNA population (10). For miRNA, the short sequence length, high
sequence similarity among family members and sequence
length variation (isomiR) all contribute to the difficulty of
miRNA quantification. In addition, recent studies have suggested that a fraction of the RNA in circulation is derived
from exogenous species including bacteria, fungi and plants
(10–14), further complicating unambiguous assignment of
the origin of many RNA species.
Due to the wealth of information provided and decreased
cost, the next generation sequencing (NGS) platform has
gradually become one of the most common tools for studying small RNAs (15). The NGS platform can resolve closely
related sequences, is not affected by sequence length variation, does not require prior knowledge of the sequence,
may provide information to identify new miRNA sequences
and allows the profiling of exogenous RNAs in the sample.
However, most of the tools (summarized in Supplementary
Table S1) for small RNA sequencing (sRNA-Seq) data analysis deliver poor sequence mapping specificity.
To address some of the small RNA analysis problems,
particularly for miRNA, we have built a comprehensive and
customizable pipeline––sRNAnalyzer, based on the framework published earlier (4,10–11). An installation package
for the pipeline and all the reference database indexes used
in the pipeline can be downloaded from http://srnanalyzer.
systemsbiology.net/. We also built a web interface for the
pipeline, which can be accessed at the same website, mainly
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for human small RNA profiling. In this paper, we introduce
the overall workflow with a description of key features, followed by performance evaluation using a synthetic miRNA
panel and biological samples.
MATERIALS AND METHODS
Similar to all other tools for NGS-based small RNA profiling, the tool described here can be grouped into three functional modules (shown in Figure 1), i.e. data pre-processing,
sequence mapping/alignment and result summarization.
The sequence mapping/alignment module is designed for
two major categories, one aimed at endogenous RNA profiling and the other for identifying RNA sequences derived
from exogenous species. With this modular design, sRNAnalyzer allows for rapid modifications of each module, for
example, adding/removing a reference sequence database,
or changing the mapping order of databases used in the
pipeline.
Data pre-processing module
In the data pre-processing module, the pipeline trims
the adapter sequences and removes empty reads (adapter
dimer). Adapter trimming is especially important for
sRNA-Seq data analysis, since most of the sequence reads
are short and may contain part or all of the adapter sequences. If the adapter sequences are not completely removed, mapping accuracy will be significantly affected.
The module also assesses the overall sequence quality and
removes low quality and low complexity reads, such as
reads containing simple repeats––homopolymer, di- or trinucleotide repeats.
Processes to trim adapters and remove low quality sequences.
To remove adapter sequences, the pipeline adapted Cutadapt (16), to remove both 3 -end and 5 -end adapter sequences. After adapter trimming, sRNAnalyzer removes
empty reads by utilizing index sequences (i.e. a 6-mer barcode embedded in the primer sequence) used for individual samples during the library construction process. If no
index/barcode information is provided, the pipeline can retrieve index information directly from raw sequence files
by calculating the top frequency of potential index sequences (Supplementary File 1––Method details). sRNAnalyzer handles degenerate bases used in adapters, such as
those in kits from Bioo (Bioo Scientific, Austin, TX, USA),
through configuring different settings/parameters in Cutadapt. The pipeline also provides options to identify and
remove other contaminant sequences commonly encountered in small RNA libraries. To reduce adapter dimer, the
Illumina TruSeq small RNA library construction kit uses
stop oligo in the library preparation process. The stop oligo
sequences (GAATTCCACCACGTTCCCGTGG) will be
incorporated into the library especially when the input
RNA concentration is low, such as libraries from various
body fluid samples. The level of stop oligo in the library
can be used as one of the criteria for library quality assessment. Our pipeline removes stop oligo sequences based on
template sequences observed from experiments from synthetic miRNA samples. For quality controls, the pipeline
uses Prinseq (17), to remove low-quality reads.

Generating unique sequence file. To accelerate sequence alignment, the pipeline uses fastx collapser
(http://hannonlab.cshl.edu/fastx toolkit/) to generate a
file where identical reads are collapsed together. The new
header of each unique FASTA sequence in the new file
contains a unique sequence ID, followed by the number
of reads that have the same sequence. When calculating
sequence abundance, the read count for each unique
sequence is added together.
Sequence mapping and alignment module
The main function of the read sequence alignment module is to determine the sequence identity by mapping the
reads against various sequence databases. Like many other
sRNA-Seq data analysis tools, sRNAnalyzer uses Bowtie
(18) alignment results to determine the identity of sequence
reads.
Sequential mapping strategy. The pipeline follows the
‘map and remove’ strategy adapted in the original report
(11) to sequentially map reads against various databases
as described (Supplementary Figure S1). The order of
databases depends on the research focus and can be changed
by the user. The sequence mapping is based on a progressive
alignment strategy––maximum mismatch allowance progressively increases from 0 to 2 for mapping against sequence databases. The error tolerance can also be adjusted
by the user.
The sequence reads can map to either the positive or negative strand of the reference sequences. In the default setting, the pipeline only counts reads mapped to the positive (forward) strand for various RNA sequence databases
(e.g. miRNA, piRNA, snoRNA, lncRNA, RefSeq, ncRNA
etc.), but counts reads mapped to both strands (±) for DNA
sequence databases (e.g. human genome, human microbiome DNA databases and bacterial genomes). For reads
mapped to the reverse (−) strand of sequences in RNAspecific databases, the results will not be included as expression values, but their mapped locations will still be reported
since these reads may have regulatory functions.
miRNA mapping. As illustrated in Supplementary Figure S2, our pipeline directly maps read sequences against
miRNA precursor sequences (annotated with mature
miRNA locations) by applying full alignment in Bowtie,
rather than using Bowtie seed alignment option as in
sRNAbench (19). Using seed alignment (only considering
matches on a seed region, default setting is 20 nt in sRNAbench) cannot control mismatch tolerance outside the
seed region, and will mix RNA editing events and SNPs
with sequencing errors. The latest sRNAbench paper (19)
also mentioned the deficiency of using seed alignment. In
our pipeline, we generated composite sequence header containing precursor sequence ID, and mature miRNA names
and coordinates during the construction of miRNA reference database. A mapped read will then be assigned to either one of the corresponding mature miRNAs (either at 5
end (-5p) or 3 end (-3p) of the precursor sequence).
With this approach, some miRNA IDs generated through
sRNAnalyzer do not exist in miRBase (20). For example, hsa-miR-101–1-3p and hsa-miR-101–2-3p share the
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Figure 1. Main framework of sRNAnalyzer. The pipeline can be divided into three functional modules which are separated by dotted lines. The data format
for each process is indicated in square brackets.

same mature sequence (hsa-miR-101–3p in miRBase 21)
but contain different sequences beyond the mature sequence. This strategy offers the advantage of obtaining all
length variations––isomiR associated with miRNA. With
mismatch allowance, we can also detect potential RNA editing events and single nucleotide polymorphisms (SNPs) associated with miRNA. We demonstrated this in a case study
using colorectal cancer (CRC) sequence dataset. To verify
potential SNPs or RNA editing issues, the pipeline will further search each mismatch event, including both mismatch
types and coordinates on genome, against dbSNP (21).
To address the concern about validity of miRNA repertoires recently raised (22–24), the pipeline also provides
MirGeneDB (24) as an option for human miRNA profiling with better annotations. The pipeline has modular designs on reference database mapping, which allows for adding/removing a customized reference sequence
database, or changing the mapping order of databases
very conveniently (through a markup configuration file).
To summarize miRNA mapping results, sRNAnalyzer uses
two read summarization strategies: single assignment and
multiple assignment approaches first introduced in sRNAbench (19). Under the single assignment approach, each
read is counted only once even when it maps to multiple reference sequences. In the multiple assignment approach, all
mapped reference sequences are counted.
Single assignment for miRNA mapping. One of the difficulties associated with miRNA profiling or measurement
is the extreme sequence similarity of some sequences, especially for mature miRNAs among family members (sequences can sometimes be identical). Under traditional approaches, identical reads from different samples may be assigned to different IDs, since the Bowtie aligner randomly
assigns all the best matching reference sequences as the top
hit. To solve this mapping issue, we adapted a local prob-

abilistic model (LPM) to assign each mapped read to the
most-likely miRNA within a sample (Supplementary Figure S3). This LPM is based on feature (sequence ID) ranking order, which is assessed by the frequency of mapped
reads (a higher ranking order indicates the specific sequence
ID has more mapped reads). Therefore, a miRNA mapping
assignment is determined by both the alignment of individual reads and the overall mapped read count distribution
among all the miRNAs within a sample.
Weighted multiple assignment approach for miRNA mapping.
Due to the nature of nucleic acid hybridization, which forms
the basis of both qRT-PCR and microarray platforms, the
results from qRT-PCR and microarray are less specific than
NGS-based profiling results. To generate results that are
in better agreement with other miRNA measurement platforms, the user can also select a weighted multiple assignment approach. For miRNA mapping, our default parameters count a perfect match (no mismatch) as 1, one mismatch as 0.8 and two mismatches count as 0.6. Users can
also change these weight factors.
Exogenous RNA mapping––ribosomal and transfer RNA filtering. Based on prior studies (4,10), most of the exogenous RNAs map to various ribosomal RNAs (rRNAs)
and transfer RNAs (tRNAs) (11,25–26). Both rRNAs and
tRNAs possess high sequence similarity among different
species, which creates uncertainty about the origin of exogenous RNA and a significant mapping problem due to multiple matches. In some cases, a single sequence read can map
to several thousand sequences in the database. For a more
accurate mapping result for exogenous RNAs, the pipeline
offers an option to filter out microbial tRNA and rRNA
sequences prior to exogenous sequence database mapping.
We tested the use of tRNA and rRNA for exogenous
species mapping using bacteria RNA dataset and found re-
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moving rRNA and tRNA sequences increased the accuracy for species assignment. However, this needs to be further tested with additional datasets. Our pipeline does allow the user to bypass the rRNA and tRNA filtering step
so that user can test the mapping accuracy with or without rRNA/tRNA filtering. Even though we ‘filter’ out the
tRNA and rRNA reads, the current pipeline still provides
tRNA and rRNA fragment mapping results. The reason we
call this a filtering step is to highlight the importance of
‘rRNA and tRNA filtering’ in the accuracy and specificity
of exogenous RNA mapping as shown in Results section.
Recently, there are many studies discovered possible regulatory roles and potential applications of tRNA or rRNA
fragments (27,28), especially in plasma or serum samples
(29). To make this clear, we also modified our pipeline by
adding specific human tRNA from GtRNAdb (30) and human rRNA databases from RDP II (31) and SILVA (32)
in the mapping steps. In addition, we provide profiles for
yRNA fragments from human transcriptome mapping results by NCBI/RefSeq (33).
Result summarization module
The result summarization module provides reports for various mapping results. The results can be summarized at different levels––from individual transcripts (such as individual miRNAs) to different phyla.
miRNA mapping results. The pipeline can summarize read
counts for each individual mature or precursor miRNA, as
well as aggregate read counts for each nucleotide across individual precursor miRNAs. Moreover, sRNAnalyzer provides mismatch counts and rates for all the possible 16 mismatch types (A|T|G|C > A|T|G|C|N) at each position. This
function allows researchers to review miRNA sequence
variations in the sample.
Summarization based on taxonomy. Besides detailed small
RNA expression profiles, the mapping results can also be
viewed at different taxonomy levels (including Phylum,
Class, Order, Family, Genus, Species and Strain/Scientific
Name). The taxonomy annotation is based on two sources:
(i) descriptions in the sequence header from the original reference sequence databases, and (ii) taxonomy information
from gi taxid obtained from NCBI (mainly for bacteria and
nt database from NCBI). For convenience, common names
for different species are also added to the summarization
results.
Datasets used in the performance evaluation study
To assess the performance and determine various parameters used in sRNAnalyzer, we used datasets generated using
both artificial and biological samples, including synthetic
miRNA, bacterial culture, human tissue and plasma samples.
Synthetic miRNA. A total of 286 synthetic miRNAs that
are commonly observed in circulation were synthesized by
Integrated DNA Technologies (Coralville, IA). We randomly assigned synthetic miRNAs to each of three plates

(Plate 1, Plate 2 and Plate 3) respectively. Six combinations of different concentrations from these three synthetic
miRNAs plates were subjected to small RNA sequencing
(GEO accession number: GSE94912), qRT-PCR (Exiqon,
Woburn, MA, USA) and microarray (Exiqon, Woburn,
MA, USA) analyses (Supplementary File 3––Tables for
synthetic miRNA pool information and measurements).
The synthetic miRNA samples are labeled with ‘Platform or library kit name’ ‘Plate 1 concentration’ ‘Plate
2 concentration’ ‘Plate 3 concentration’. For example,
NEB 10 1 0.1 represents the synthetic miRNA sample with
NEB NEBNext® Small RNA Library Prep library kit
(New England Biolabs, Ipswich, MA, USA) using 10 ng of
pooled synthetic miRNAs from plate 1, 1 ng of pooled miRNAs from plate 2 and 0.1 ng of pooled miRNAs from plate
3.
Bacterial culture. To test the capability and accuracy of
sRNAnalyzer on exogenous RNA mapping, we re-analyzed
the small RNAseq data from our prior report (25) on
RNA in outer membrane vesicles (OMV) derived from Escherichia coli K-12 substrain MG1655. The bacteria were
grown in Luria-Bertani (LB) broth at 37◦ C. The small RNA
libraries from the bacterial culture, OMV-containing supernatant, OMV-free supernatant and unused fresh LB media were generated with the Illumina TruSeq Small RNASeq Prep Kit (San Diego, CA, USA). In the original study,
processed reads (after removing adapter sequences) were
mapped directly against the E. coli K-12 substrain MG1655
reference genome (accession number: NC 000913.2).
Human tissue and plasma data. To test the performance of
sRNAnalyzer on human samples, we used two public domain datasets. A human CRC tissue miRNA study (GEO
accession number: GSE46622 or SRA accession number:
SRP022054) (34) and our prior human CRC plasma study
(SRA accession number: ERP002414) (11). These datasets
allow us to compare the results from sRNAnalyzer with
published results. The CRC tissue study contains the primary tumor tissues, adjacent normal colon epithelium and
liver metastases from eight patients. The small RNA libraries were made with the Illumina v1.5 Small RNA-Seq
Prep Kit (3 adapter: TCGTATGCCGTCTTCTGCTTG,
5 adapter: GTTCAGAGTTCTACAGTCCGACGATC).
In the original report, the adapters were trimmed using
BLAT (35) and then the processed sequences were mapped
directly against the human genome (hg19) with the BWA
aligner. The plasma dataset contains nine different samples, including plasma samples from three CRC patients,
three Ulcerative Colitis (UC) patients and three normal
controls. The small RNA libraries were generated with the
Illumina v1.5 Small RNA-Seq Prep Kit (3 adapter: ATCT
CGTATGCCGTCTTCTGCTTG, 5 adapter: GTTCAG
AGTTCTACAGTCCGACGATC).
RESULTS
Synthetic miRNAs
One of the challenges associated with miRNA
profiling/measurement is the inconsistency of results
from different platforms. This makes it difficult to compare
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data generated from different platforms or to use different
platforms for verification of results. This is especially true
for results between NGS and other platforms, since NGS
does not utilize hybridization of oligonucleotides/primers
for its measurement. To better align the sequencing results
with qRT-PCR and microarray results, we used measurement results from different platforms based on the 286
synthetic miRNAs to evaluate mapping parameters.
The comparison results between different measurement
platforms under different synthetic miRNA composition
are shown in Figure 2. The concentration distribution of
miRNA profiles from miRNA array showed good correlation with input miRNA concentration (Figure 2A). For
example, the third sample––Array 10 1 0.1, with 10 ng, 1
ng and 0.1 ng of pooled miRNAs from plate 1, 2 and 3
respectively, has Log2-transformed hybridization intensities around 9.5, 6.5 and 3.5 on average for plate 1, 2 and
3. The results from qRT-PCR (qPCR 10 10 10) correlated
with the corresponding microarray results (Array 10 10 10,
and Array 10 10 1) (Figure 2B). However, the correlation
between microarray and qRT-PCR results dropped significantly when lower concentrations of synthetic miRNAs
were involved.
The correlation coefficients between miRNA profiling results generated from miRNA array and sRNA-Seq under
different mapping assignment approaches are summarized
in Figure 2C and D. The NGS platform can differentiate
different compositions of synthetic miRNA, and the NGS
mapping results showed good correlation with miRNA array (Figure 2E) and qRT-PCR (Figure 2F) data. In general,
NGS results generated using the multiple assignment mapping strategy with some mismatch allowance provided better correlation with microarray and qRT-PCR results compared to single assignment with no mismatches allowed.
The weighted approach to adjust the contribution for different levels of mismatch on the overall mapping results
further enhanced the correlation between NGS profiling results with either microarray or qRT-PCR. However, the optimal mismatch allowance conditions are different between
microarray and qRT-PCR. For example, multiple assignment with a maximum of two mismatches (using weight adjustment factor of one for no mismatch, 0.8 for one mismatch and 0.6 for two mismatches) showed higher correlation with microarray results, while multiple assignment using a maximum of one mismatch (using a parameter of one
for no mismatch and 0.8 for one mismatch) showed higher
correlation with qRT-PCR. This is consistent with the idea
that the qRT-PCR based measurement is more specific than
the microarray-based measurement. However, this may also
depend on differences in PCR primer or microarray probe
design between different vendors. Users can adjust the parameters to fit their experimental platform and condition.
Nevertheless, sRNAnalyzer provides options to better align
the sequencing results with other platforms, which will be
useful for users to verify sRNA-Seq results with qRT-PCR
or other platforms.
Analyzing small RNA in human samples with sRNAnalyzer
The miRNA mapping can be affected by some common
features associated with miRNA, including length variation

(isomiR), sequence polymorphism, RNA editing and high
sequence similarity among family members. To solve these
issues, sRNAnalyzer uses a combination of approaches, including mapping to miRNA precursors instead of mature
miRNA and different levels of error tolerance in combination with the LPM. To test the performance of sRNAnalyzer on complex biological samples, we downloaded
the raw sequencing data of a CRC study from NCBI/SRA
database (SRP022054). The original study used qRT-PCR
to verify several differentially expressed miRNAs identified
by NGS (34).
We used the sRNAnalyzer, with multiple assignment
and maximum of one mismatch, to test whether we could
identify those validated differentially-expressed miRNAs in
CRC. After running the dataset through sRNAnalyzer, we
performed a differential analysis based on the mapping results. To compare data between different samples across different experiments, the mapped read counts were normalized with Log2-transformed reads per million (RPM) reads
mapped to the reference database at each step. This normalization method is most similar to percentage. The topranked differential miRNAs identified by sRNAnalyzer (tumor versus normal) are shown in Table 1 and include all
qRT-PCR verified miRNAs. This suggests that the results
from sRNAnalyzer agree with the original study (34). The
fold changes from the qRT-PCR verification study matched
with results from sRNAnalyzer better than the results from
the original report. For example, miR-1 is the miRNA
showing the most concentration difference in both qRTPCR and sRNAnalyzer based analyses.
When one mismatch in miRNA mapping was allowed
(user adjustable), the sRNAnalyzer provided a summary file
containing both match and mismatch profiles (read counts)
for every nucleotide across the miRNA precursor sequence.
An example of summarized read count distributions for
both match and mismatch events for hsa-mir-1–1 is shown
in Figure 3. The mismatch rate at nucleotide position 67
(first nucleotide of the precursor sequence is 0) is lower
in normal tissue samples, compared to metastatic tissues.
Whether this relates to disease status remains to be determined. This function in sRNAnalyzer allows the user to
identify miRNA associated RNA editing events as well as
sequence polymorphisms.
To show a global view of small RNAs in these tissue samples, we further performed differential analysis on piRNA,
snoRNA and lncRNA profiles generated from sRNAnalyzer with single assignment and no mismatch. From Supplementary Tables S2–4, we can see that there are several interesting small RNAs differentially expressed in tumor tissues and significantly upregulated in metastases tissues.
Exogenous RNA mapping with sRNAnalyzer
Exogenous species-derived RNAs, especially from bacteria
and fungi, have been observed in human and murine samples (11,13–14,26). Even though the source, abundance and
function of exogenous RNA remains controversial (36), the
ability to accurately quantify and map the origin of exogenous sequences is critical to assess the diversity and possible function of these RNAs. We incorporated an exogenous
RNA mapping process in sRNAnalyzer.
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Figure 2. Comparison of miRNA profiles from sRNA-Seq, miRNA array and qRT-PCR platforms for synthetic miRNA samples. (A) Distribution of
miRNA profiles from miRNA array on three plates; (B) Correlation between miRNA profiles from miRNA array and qRT-PCR; (C) Correlation between
miRNA profiles from miRNA array and sRNA-Seq using single assignment approach; (D) Correlation between miRNA profiles from miRNA array
and sRNA-Seq using multiple assignment approach; (E) Approximation from sRNA-Seq to miRNA array; and (F) Approximation from sRNA-Seq to
qRT-PCR.

The conservation of rRNA and tRNA sequences among
different species often causes mapping issues since a single
read may assign to several hundred species. To obtain more
reliable information on the origin of exogenous RNA, sRNAnalyzer includes optional rRNA and tRNA filtering steps.
To test the effect of rRNA and tRNA filtering steps on
the exogenous RNA mapping accuracy, we used the small
RNAseq data from a previous bacterial out membrane vesicle (OMV) study (25). In this study, E. coli K-12 (MG
1655) was cultured in standard LB growth medium and
samples include RNA extracted from bacteria (RNAintra ),
bacterial OMV particles (RNAexOMV ), OMV-depleted me-

dia (RNAexOMV-free ), cultured LB after removing bacteria
(RNALB-cultured ) and fresh LB (RNALB ).
We first input raw read sequences into the data preprocessing module of our pipeline, including the stop oligo removing step, since these samples were made by Illumina
TruSeq small RNA library kit. For the RNAexOMV sample,
we can see that around 20% reads mapped to the stop oligo
(stp) sequences have been removed (Supplementary Figure
S4), which not only improved the overall mapping rate but
also increased the mapping efficiency.
We then ran the trimmed/clean reads through the remaining pipeline, which allowed us to test (i) whether
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Table 1. Differential analysis of miRNA profiles for human tissue samples from a CRC study (GEO accession number: GSE46622 or SRA accession
number: SRP022054)
miRNA

T/N FC

T/N pVal

M/N FC

M/N pVal

M/T FC

M/T pVal

hsa-miR-1–3p
hsa-miR-133a-3p
hsa-miR-194–1-3P
hsa-miR-375
hsa-miR-143–5p
hsa-miR-133b
hsa-miR-129–2-3p
hsa-miR-129–1-3p
hsa-miR-1224–5p
hsa-miR-147b
hsa-miR-124–3p
hsa-miR-490–3p
hsa-miR-215–3p
hsa-miR-133a-5p
hsa-miR-145–3p
hsa-miR-96–5p
hsa-miR-182–5p
hsa-miR-183–5p
hsa-miR-135a-5p
hsa-miR-122–5p
hsa-miR-31–3p
hsa-miR-135b-5p
hsa-miR-31–5p

−8.22250
−4.76817
−4.30349
−4.15678
−4.05022
−3.42637
−3.41944
−3.39301
−3.01311
−2.74872
−2.70090
−2.68564
−2.64760
−2.31880
−2.26530
2.55000
3.42372
3.99934
4.57508
5.42554
6.04394
6.65842
17.06142

0.00221
0.00251
0.02117
0.01461
0.00980
0.00068
0.02247
0.01807
0.00238
0.02911
0.00639
0.02562
0.07514
0.00400
0.02788
0.01849
0.03417
0.01719
0.00792
0.08238
0.00683
0.00524
0.00031

−12.19746
−8.74696
−6.83087
−1.40532
−3.44819
−3.98052
−3.91576
−3.05203
−0.49318
−4.74095
−1.08949
−3.50480
−5.24797
−3.63812
−4.19600
4.31795
7.79898
7.40056
7.91757
34.37772
2.12517
10.20095
10.03755

0.00019
0.00009
0.00324
0.10508
0.00970
0.00014
0.00998
0.01421
0.23264
0.00365
0.14865
0.01366
0.01009
0.00081
0.00459
0.00278
0.00119
0.00479
0.00206
0.00572
0.01529
0.00138
0.00234

−0.39062
−0.59894
−0.29064
0.72822
0.02421
−0.02076
−0.01681
0.00903
1.06825
−0.26982
0.35959
−0.05444
−0.44050
−0.14794
−0.29520
0.23145
0.88800
0.51921
0.45545
12.48896
−1.00130
0.37638
−0.92609

0.25391
0.10591
0.29476
0.22547
0.41680
0.35883
0.41124
0.42976
0.14720
0.29074
0.26224
0.24816
0.29178
0.13683
0.21543
0.25813
0.17776
0.25077
0.20791
0.06981
0.15600
0.24436
0.17938

Note: N––Normal, T––Tumor, M––Metastasis, FC––Fold Change and pVal––P-Value. Nine miRNAs validated by qRT-PCR in the original study (34)
are highlighted (bold).

Figure 3. Example of summarized read count distributions for every nucleotide for both match and mismatch events across the miRNA precursor sequence
(has-mir-1–1).

the parameters used for endogenous reference sequence
database (mainly for human in this scenario) mapping process in sRNAnalyzer would filter out too many informative bacterial sequences and (ii) whether sRNAnalyzer can
correctly identify the bacterial species. We tested various

options for exogenous mapping including with/without
rRNA/tRNA filtering, and with/without LPM.
Under the settings single assignment with LPM, most of
the RNAintra reads mapped to bacteria (Figure 4A), which
suggests rigorous human reference sequence mapping steps
(allowing two mismatches) do not remove a significant
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Figure 4. Overall mapping ratios and taxonomy summarization for Escherichia coli bacterial culture samples. (A) Overall domain mapping ratios; (B)
Taxonomy summary at Genus level using ribosomal RNA (rRNA) filtering and applying a local probabilistic model (LPM); (C) Taxonomy summary at
Genus level using rRNA filtering but without LPM; and (D) Taxonomy summary at Genus level neither using rRNA filtering nor applying LPM.

fraction of the sequence reads (over 95% of sequence
reads) prior to bacterial sequence database mapping. Unlike the RNAintra samples, many reads from the RNAexOMV ,
RNAexOMV-free , RNALB-cultured and RNALB samples mapped
to fungi and mammals. This is not surprising since these
four samples were extracted from LB medium and the standard LB medium does contain yeast extract and tryptone
(from mammalian milk).

To compare these samples under different analytical approaches, we used log2 transformed RPM mapped reads. At
the genus level, Escherichia has the most mapped sequence
reads from RNAintra , RNAexOMV and RNAexOMV-free (Figure 4B). In results for RNAintra , the second top-ranked
genus was Shigella, which is evolutionarily close to Escherichia, followed by Salmonella, which shares 18% of
its genome with E. coli substrain MG1655. It should be
noted that the RNAexOMV and RNAexOMV-free samples were
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more similar to the RNAintra sample at genus (Figure 4B),
species (Supplementary Figure S5) and strain levels (Supplementary Figure S6), even though they are more similar
to RNALB-cultured and RNALB samples at the domain level
(Figure 4A). These results indicated that using default setting, sRNAnalyzer (rRNA/tRNA filtering with LPM) can
successfully identify specific bacterial species from samples.
Escherichia is still the top ranking genus for RNAintra
and RNAexOMV-free samples (Figure 4C), but not for the
RNAexOMV , when LPM was not used. This suggests that
exogenous reference sequence mapping without LPM has
less specificity even if rRNA and tRNA filtering step is applied. Without rRNA and tRNA filtering, Serratia was incorrectly identified as the top ranking genus for RNAintra
(Figure 4D). This suggests that the rRNA/tRNA filter step
can improve the accuracy of exogenous sequence mapping.
Analyzing exogenous RNA in human samples with sRNAnalyzer
To test the ability of sRNAnalyzer to identify exogenous
RNAs in samples, we used a dataset of plasma samples
from CRC patients that we published earlier (11). The
data contains nine human plasma samples––three from
CRC patients, three from Ulcerative Colitis (UC) patients
and three from healthy individuals (Norm). We used log2transformed and RPM normalized data for comparison.
Despite different clinical conditions, the overall profile of
mapped sequence reads at domain level is similar among the
samples (Figure 5A) which is consistent with prior findings.
However, at the genus level, some CRC samples showed
higher concentrations of Pseudomonas (crc1 and crc2) and
Ralstonia (crc2 and crc3) derived sequences compared to
UC and Norm samples (Figure 5B and C).
We further identified RNA derived from two bacterial
species––Pseudomonas fluorescens and Ralstonia pickettii in
the three CRC samples that were more abundant than other
samples. When compared to human CRC tissue samples
(34) reanalyzed with sRNAnalyzer, the abundance of RNA
derived from Pseudomonas and Ralstonia were both significantly higher (>3-fold difference with P-value < 0.05) in
metastatic tissue samples (Figure 6B and C). We did not see
this correlation between tissue and plasma datasets without rRNA/tRNA filtering. This also suggests the potential
of identifying disease-associated exogenous species-derived
RNA in circulation using rRNA and tRNA filtering with
LPM in sRNAnalyzer.
DISCUSSION AND CONCLUSIONS
There are many experimental and data analysis challenges
in the field of small RNA profiling, especially when dealing
with body fluid samples. To improve the reliability of NGSbased small RNA profiling, sRNAnalyzer adopts a comprehensive adapter trimming strategy and sequence quality assessment in the data preprocessing module. For sequence mapping, we developed a flexible database searching approach to fit specific goals for different studies. We
used several public domain datasets to evaluate the performance and determine the proper setting of various parameters in sRNAnalyzer. In the result summarization module,

sRNAnalyzer provides several reporting formats for users
to view and inspect the mapping results. Compared to other
tools, the sRNAnalyzer has many enhanced features including (i) modular pipeline design, (ii) rigorous data preprocessing steps, (iii) endogenous and exogenous RNA mapping capability, (iv) use of precursor miRNA sequences
annotated with mature sequence information for miRNA
mapping, (v) use of LPM (local probability mapping) strategy to increase mapping specificity, (vi) extensive rRNA and
tRNA filtering steps to enhance the accuracy of exogenous
RNA mapping and (vii) various levels of result summarization. These features increase the flexibility for users to inspect the results and gain a global view of the small RNA
in the sample.
For miRNA profiling, sRNAnalyzer adopted both the
single and multiple assignment approaches as introduced
in sRNAbench (19) to report the miRNA mapping results.
Both approaches support different levels of error tolerance,
from perfect match to two mismatches allowed. The single assignment approach based on LPM provides a more
reliable picture of the RNA profile in a sample, while results from the multiple assignment approach provide better agreement with results from other miRNA measurement platforms such as microarray and qRT-PCR, especially when applying weighted correction factors for different levels of mismatch allowance. The final estimation of
the expression values were calculated with all mapped reads
and summarized as miRNA profiling results. This weight
approach actually considered sequence mismatches caused
by all possible reasons including SNPs, RNA editing issues,
as well as sequence errors.
Since a significant fraction of circulating RNAs are the
degraded products of large transcripts, sRNAnalyzer includes a number of endogenous sequence databases including various noncoding RNAs, protein coding transcripts
and genomic DNA to gain a comprehensive profile of RNA
in circulation. For these endogenous sequences, sRNAnalyzer uses ‘map and remove’ structure (i.e. only unmapped
reads will be fed into next steps) with progressive alignment strategy to sequentially map reads against various
databases. The mapping order of databases and the error
tolerance on each mapping step depend on the research focus. This strategy can enrich the focused small RNA family,
while may also bring a certain level of bias due to multiple alignments. To avoid this bias, sRNAnalyzer provides a
very convenient way to change the mapping order and mismatch allowance by simply changing a text-based configuration file instead of reprogramming.
The extensive endogenous sequence mapping step is critical for exogenous sequence mapping since it removes all
possible endogenous sequence reads. This may also raise
the concern regarding the possibility of removing too many
reads derived from exogenous species. To address this concern, we tested our pipeline using a dataset derived from
RNA samples extracted from cultured bacteria. Most of the
bacteria-derived reads still passed the rigorous endogenous
‘filtering step’ and correctly mapped to bacteria species
(Figure 4A). This suggests that the rigorous human reference sequence mapping steps (allowing a maximum of two
mismatches) do not remove significant fraction of the bac-
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Figure 5. Overall domain mapping ratios and taxonomy summarization for human plasma samples from an exogenous RNA spectra study. (A) Overall
domain mapping ratios; and (B) Taxonomy summary at Genus level; and (C) Taxonomy summary at Species level for human plasma samples from an
exogenous RNA spectra study (SRA Session: ERP002414).

teria sequence reads (over 95% of sequence reads still remained).
Due to high sequence conservation of rRNA and tRNA
sequences across species, sRNAnalyzer offers users an option to remove these reads prior to exogenous sequence
mapping. We showed that rRNA and tRNA filtering is critical to identify the correct bacterium species in the case study
of bacterial culture samples (Figure 4). To avoid information loss, sRNAnalyzer can summarize reads mapped to exogenous RNAs at different taxonomy levels with or without

considering those filtered rRNAs/tRNAs, although the default setting is the latter one. In addition, the use of LPM
can further enhance the specificity of exogenous RNA mapping. Our pipeline can also be used for samples from different species by making specific databases for different species
and changing the order of mapping steps in the configuration files. Currently we have configuration files for human,
mouse, rat, horse, macaque and plant for different research
focuses.
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Figure 6. Overall mapping ratios and taxonomy summarization for human tissue samples from a CRC study. (A) Overall domain mapping ratios; (B)
Taxonomy summary on Pseudomonas; and (C) Distribution of taxonomy summary on Pseudomonas for human tissue samples from a CRC study (SRA
Session: SRP022054).

In summary, sRNAnalyzer is a full function, customizable small RNA analysis pipeline for NGS data. It can effectively map both endogenous and exogenous RNA. It also
offers different levels of detail in the mapping results––from
individual sequence reads, transcripts, species to domain.
This allows users to gain a better picture of the complexity
of small RNA in samples.
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